Important safety bulletin from ISMP Canada

May 29, 2019

A recent mix-up between methadone and buprenorphine-naloxone for a patient’s opioid agonist therapy led to an important safety bulletin from the Institute for Safe Medication Practices (ISMP) Canada. ISMP recommends pharmacies use standardized documentation templates to avoid such mistakes.

For more, visit the ISMP Canada website.

← Previous ArticleNext Article →